These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11606078)

  • 81. Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer.
    Sakai K; Kaku T; Kamura T; Kinukawa N; Amada S; Shigematsu T; Hirakawa T; Kobayashi H; Ariyoshi K; Nakano H
    Gynecol Oncol; 1999 Mar; 72(3):360-6. PubMed ID: 10053108
    [TBL] [Abstract][Full Text] [Related]  

  • 82. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer.
    Lee JH; Park SR; Chay KO; Seo YW; Kook H; Ahn KY; Kim YJ; Kim KK
    Cancer Res; 2004 Jun; 64(12):4235-43. PubMed ID: 15205336
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Decreased xanthine oxidoreductase (XOR) is associated with a worse prognosis in patients with serous ovarian carcinoma.
    Linder N; Bützow R; Lassus H; Lundin M; Lundin J
    Gynecol Oncol; 2012 Feb; 124(2):311-8. PubMed ID: 22044687
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical cancer.
    Schindl M; Birner P; Bachtiary B; Breitenecker G; Selzer E; Oberhuber G
    Anticancer Res; 2000; 20(6B):4551-5. PubMed ID: 11205303
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases.
    Maurer CA; Graber HU; Friess H; Beyermann B; Willi D; Netzer P; Zimmermann A; Büchler MW
    Surgery; 1999 Nov; 126(5):869-80. PubMed ID: 10568187
    [TBL] [Abstract][Full Text] [Related]  

  • 86. p53 and mdm2 as prognostic indicators in patients with epithelial ovarian cancer: a multivariate analysis.
    Dogan E; Saygili U; Tuna B; Gol M; Gürel D; Acar B; Koyuncuoğlu M
    Gynecol Oncol; 2005 Apr; 97(1):46-52. PubMed ID: 15790436
    [TBL] [Abstract][Full Text] [Related]  

  • 87. KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma.
    Liu FS; Chen JT; Dong JT; Hsieh YT; Lin AJ; Ho ES; Hung MJ; Lu CH
    Am J Pathol; 2001 Nov; 159(5):1629-34. PubMed ID: 11696423
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Relationship between expression of KAI1 metastasis suppressor gene, mRNA levels and p53 in human bladder and prostate cancer cell lines.
    Jackson P; Grimm MO; Kingsley EA; Brosius U; Antalis T; Yardley G; Russell PJ
    Urol Oncol; 2002; 7(3):99-104. PubMed ID: 12474542
    [TBL] [Abstract][Full Text] [Related]  

  • 89. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.
    Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M
    Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Prognostic factors in ovarian epithelial cancer].
    Nishida T
    Gan To Kagaku Ryoho; 1996 May; 23(6):805-9. PubMed ID: 8645035
    [TBL] [Abstract][Full Text] [Related]  

  • 91. KAI1/CD82, a tumor metastasis suppressor.
    Liu WM; Zhang XA
    Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Loss of KAI1/CD82 expression in bone and soft tissue tumors is not associated with lung metastasis.
    Arihiro K; Inai K
    Pathol Res Pract; 2001; 197(9):627-33. PubMed ID: 11569927
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma.
    Tagawa K; Arihiro K; Takeshima Y; Hiyama E; Yamasaki M; Inai K
    Jpn J Cancer Res; 1999 Sep; 90(9):970-6. PubMed ID: 10551326
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Expression of vasohibin-1, MACC1 and KA11 proteins in serous ovarian cancer and their clinical significance].
    Yu L; Mao X; Jiao Y; Song W; Wang D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 44(12):1344-1352. PubMed ID: 31969498
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The expression of ubiquitin-conjugating enzyme E2C and KAI1 in ovarian carcinoma and their clinical significance.
    Gong Y; Wang D; Lin L; Dai J; Yu L
    Medicine (Baltimore); 2019 Nov; 98(46):e17896. PubMed ID: 31725636
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.
    Geradts J; Maynard R; Birrer MJ; Hendricks D; Abbondanzo SL; Fong KM; Barrett JC; Lombardi DP
    Am J Pathol; 1999 Jun; 154(6):1665-71. PubMed ID: 10362791
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Expression of KAI1 gene in non-small cell lung cancer and its relationship with P53].
    Guo C; Pan T; Tang Y; Zhou Y; Zheng Z
    Zhongguo Fei Ai Za Zhi; 2005 Jun; 8(3):190-4. PubMed ID: 21190617
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Role of tumor metastasis suppressor gene KAI1 in development of colorectal cancer].
    Yang J; Liu FX; Yan XC; He GY; Liu LM
    Ai Zheng; 2003 May; 22(5):533-6. PubMed ID: 12753720
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Expression of KAI1 protein in tissue microarray and its biological significances in patients with lung cancer].
    Liu T; Wang X; Zhu C; Li Y; Sun C; Wang A
    Zhongguo Fei Ai Za Zhi; 2005 Apr; 8(2):116-9. PubMed ID: 21189178
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Inverse correlation between KAI1 mRNA levels and invasive behaviour in bladder cancer cell lines.
    Jackson P; Kingsley EA; Russell PJ
    Cancer Lett; 2000 Aug; 156(1):9-17. PubMed ID: 10840154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.